Related Experiment Video
Updated: Sep 16, 2025

Synthesis, Functionalization, and Characterization of Fusogenic Porous Silicon Nanoparticles for Oligonucleotide Delivery
Published on: April 16, 2019
Effects of surface functional modification of mesoporous silica nanoparticles on oral insulin delivery: A review
Jie Zheng1, Long Wan1, Xiaowei Zhang2
1Department of Pharmacy, the First Hospital of China Medical University, 155 Nanjing North Street, Shenyang 110001, Liaoning, China; School of Pharmacy, China Medical University, 77 Puhe Road, Shenyang 110122, Liaoning, China.
Abstract:
Convenient and painless oral formulations of insulin are more accessible to patients than subcutaneous insulin, which is inconvenient to use and has more adverse outcomes. However, due to the intrinsic properties of insulin, and the harsh environments and physiological barriers in the gastrointestinal tract, the structure of insulin is susceptible to destruction after oral administration, resulting in drug inactivation. Mesoporous silica nanoparticles (MSNs), exhibiting advantages such as the well-developed pore network and good biocompatibility, ensures the efficient loading of insulin, protect the activity and dominant conformation of insulin. This opens new ideas for oral insulin delivery. However, due to the complex environment of the gastrointestinal tract, unmodified MSNs are not sufficient to overcome the multiple barriers of the gastrointestinal tract for efficient delivery of oral insulin. In order to make insulin oral administration more efficient, researchers have designed many different modifications on the surface of MSNs. In this review, we present the challenges facing oral insulin. The synthetic methods and physical properties of MSNs used as drug carriers are summarized. The surface modifications of MSNs currently used as carriers for insulin delivery are summarized. The advantages and disadvantages of MSNs with different surface modifications as carriers for oral administration of insulin are discussed. The limitations and future perspectives of the current MSNs and surface-modified MSNs in oral insulin delivery systems are also written.
Related Concept Videos
Factors Affecting Dissolution: Particle Size and Effective Surface Area
Insulin Formulations: Types and Delivery
Short-acting insulins are divided into...
Oral Hypoglycemic Agents: Glinides
Oral Hypoglycemic Agents: Sulfonylureas
Oral Hypoglycemic Agents: Biguanides and Glitazones
Insulin: Dosing Regimen and Adverse Effects
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...

